Bone marrow and plasma FGF-23 in heart failure patients: novel insights into the heart-bone axis.
Beatrice von JeinsenKateryna SopovaLars PalapiesDavid M LeistnerStephan FichtlschererFlorian H SeegerJörg HonoldStefanie DimmelerBirgit AßmusAndreas M ZeiherSteffen D KriechbaumPublished in: ESC heart failure (2019)
In CHF patients, FGF-23 is elevated in bone marrow plasma and is independently associated with heart failure severity and all-cause mortality. The failing heart seems to interact via FGF-23 within a heart-bone axis.